CCRL1
CCRL1 (Chemokine (C-C motif) receptor-like 1) is a protein that in humans is encoded by the CCRL1 gene. This protein is a member of the G protein-coupled receptor family, which are integral membrane proteins that respond to various stimuli like light, hormones, and neurotransmitters.

Function[edit]
The CCRL1 protein is a receptor for chemokines, a family of small molecules that regulate cell trafficking of various types of leukocytes. The CCRL1 protein is closely related to another chemokine receptor, CCR3, and has been shown to specifically bind to the chemokine CCL19.
Clinical significance[edit]
Alterations in the CCRL1 gene have been associated with various diseases, including asthma, rheumatoid arthritis, and cancer. In particular, overexpression of CCRL1 has been observed in several types of cancer, suggesting a potential role in tumor progression.
Research[edit]
Research on CCRL1 is ongoing, with studies investigating its role in immune response, inflammation, and cancer progression. Understanding the function of CCRL1 could potentially lead to new therapeutic strategies for these conditions.
See also[edit]
- Chemokine receptor
- G protein-coupled receptor
- Chemokine
- Leukocyte
- Asthma
- Rheumatoid arthritis
- Cancer
References[edit]
| Cytokine receptors | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Human Proteins | ||||||||
|---|---|---|---|---|---|---|---|---|
This human proteins-related article is a stub. You can help WikiMD by expanding it.
|
| Genetics and Genomics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian